Total synthesis of (+)-geldanamycin and (-)-o-quinogeldanamycin with use of asymmetric anti- and syn-glycolate aldol reactions

Organic Letters

Volumn 4, Issue 20, 2002, Pages 3549-3552

  Andrus, Merritt B ^a   Meredith, Erik L ^a   Simmons, Bryon L ^a   Sekhar, B B V Soma ^a   Hicken, Erik J ^a  

^a Brigham Young University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; BENZOQUINONE DERIVATIVE; GELDANAMYCIN; HEAT SHOCK PROTEIN 90; MACROCYCLIC LACTAM; QUINOGELDANAMYCIN; QUINONE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; SYNTHESIS;

ANTIBIOTICS, ANTINEOPLASTIC; BENZOQUINONES; HSP90 HEAT-SHOCK PROTEINS; LACTAMS, MACROCYCLIC; MOLECULAR STRUCTURE; QUINONES;

EID: 0037015443     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0267432     Document Type: Article

References (34)

1. Rinehart, K. L. Acc. Chem. Res. 1972, 5, 57.
2. Herbimycin A: (a) Nakata, M.; Osumi, T.; Ueno, A.; Kimura, T.; Tamai, T.; Tatsuda, K. Tetrahedron Lett. 1991, 32, 6015.
3. Macbecin I: (b) Baker, R.; Castro, J. L. J. Chem. Soc., Perkin Trans. 1990, 47.
4. (c) Evans, D. A.; Miller, S. J.; Ennis, M. D. J. Org. Chem. 1993, 58, 471.
5. Panek, J. S.; Xu, F.; Rondon, A. C. J. Am. Chem. Soc. 1998, 120, 4413.
6. (a) De Boer, C.; Meulman, P. A.; Wnuk, R. J.; Peterson, D. H. J. Antibiol. 1970, 23, 442.
7. (b) Rinehart, K. L.; Sasaki, K.; Slomp, G.; Grostic, M. F.; Olson, E. C. J. Am. Chem. Soc. 1970, 92, 7591.
8. GA derivatives: (a) Rinehart, K. L.; McMillan, M. W.; Witty, T. R.; Tipton, C. D.; Shield, L. S.; Li, L. H.; Reusser, F. Bioorg. Chem. 1977, 6, 353.
9. (b) Schnur, R. C.; Corman, M. L. J. Org. Chem. 1994, 59, 2581. Schnur, R. C.; Corman, M. L.; Gallaschun, R. J.; Cooper, B. A.; Dee, M. F.; Doty, J. L.; Muzzi, M. L.; Moyer, J. D.; DiOrio, C. I.; Barbacci, E. G.; Miller, P. E.; O'Brien, A. T.; Morin, M. J.; Foster, B. A.; Pollack, V. A.; Savage, D. M.; Sloan, D. E.; Pustilnik, L. R.; Moyer, M. P. J. Med. Chem. 1995, 38, 3806.
10. (b) Schnur, R. C.; Corman, M. L. J. Org. Chem. 1994, 59, 2581. Schnur, R. C.; Corman, M. L.; Gallaschun, R. J.; Cooper, B. A.; Dee, M. F.; Doty, J. L.; Muzzi, M. L.; Moyer, J. D.; DiOrio, C. I.; Barbacci, E. G.; Miller, P. E.; O'Brien, A. T.; Morin, M. J.; Foster, B. A.; Pollack, V. A.; Savage, D. M.; Sloan, D. E.; Pustilnik, L. R.; Moyer, M. P. J. Med. Chem. 1995, 38, 3806.
11. (c) Kuduk, S. D.; Harris, C. R.; Zheng, F. F.; Sepp-Lorenzino, L.; Ouerfelli, Q.; Rosen, N.; Danishefsky, S. J. Bioorg. Med. Chem. Lett. 2000, 10, 1303.
12. Whitesell, L.; Shifrin, S. D.; Schwab, G.; Neckers, L. M. Cancer Res. 1992, 52, 1721.
13. Whitesell, L.; Mimnaugh, E. G.; De Costa, B.; Myers, C. E.; Neckers, L. M. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 8324.
14. Lawrence, D. S.; Niu, J. Pharmacol. Ther. 1998, 77, 81.
15. (a) Stebbins, C. E.; Russo, A. A.; Schneider, C.; Rosen, N.; Hartl, F. U.; Pavletich, N. P. Cell 1997, 89, 239.
16. (b) Roe, S. M.; Prodromou, R. O.; Ladbury, J. E.; Piper, P. W.; Pearl, L. H. J. Med. Chem. 1999, 42, 260.
17. (a) Andrus, M. B.; Soma Sekhar, B. B. V.; Meredith, E. L.; Dalley, N. K. Org. Lett. 2000, 2, 3035.
18. (b) Andrus, M. B.; Meredith, E. L.; Soma Sekhar, B. B. V. Org. Lett. 2001, 3, 259.
19. Andrus, M. B.; Mendenhall, K. G.; Meredith, E. L.; Soma Sekhar, B. B. V. Tetrahedron Lett. 2002, 43, 1789-1792.
20. Andrus, M. B.; Soma Sekhar, B. B. V.; Turner, T. M.; Meredith, E. L. Tetrahedron Lett. 2001, 42, 7197.
21. (a) Abiko, A.; Liu, J.-F.; Masamune, S. J. Am. Chem. Soc. 1997, 119, 2586.
22. (b) Yoshimitsu, T.; Song, J. J.; Wang, G.-Q.; Masamune, S. J. Org. Chem. 1997, 62, 8978.
23. (c) Abiko, A.; Liu, J.-F.; Buske, D. C.; Moriyama, S.; Masamune, S. J. Am. Chem. Soc. 1999, 121, 7168.
24. (d) Liu, J.-F.; Abiko, A.; Pei, Z.; Buske, D. C.; Masamune, S. Tetrahedron Lett. 1998, 39, 1873.
25. Hirai, Y.; Aida, T.; Inoue, S. J. Am. Chem. Soc. 1987, 111, 3062.
26. Still, W. C.; German, C. Tetrahedron Lett. 1983, 24, 4405.
27. For a typical use of this approach see: Keck, G. E.; Palani, A.; McHardy, S. F. J. Org. Chem. 1994, 59, 3113. 2-Methylcinnamaldehyde gave a 3:2:2:1 mixture of products with the methoxyacetyloxazolidinone boron enolate.
28. Roush, W. R.; Sciotti, R. J. J. Am. Chem. Soc. 1998, 120, 7411.
29. Lalancette, J. M.; Freche, A.; brindle, J. R.; Laliberte, M. Synthesis 1972, 526.
30. Kocovsky, P. Tetrahedron Lett. 1986, 27, 5521.
31. Compound 19 was formed by using the conditions found in ref 4b. nOe enhancements for 19: C17-OH and C18-OMe 1.54%, C20-NH and C21-OMe 4.1%.
32. Kita, Y.; Hashizume, M.; Harayama, Y.; Morioka, H.; Tohma, H. Tetrahedron Lett. 2001, 42, 6899.
33. These details will be reported in a full account.
34. Musgrave, O. C. Chem. Rev. 1969, 69, 9.